To determine whether the changes in these epigenetic regulator expression patterns are generic responses to LDE225 in all medulloblastomas, we also analyzed Ptch;p53 SI-CSC and SD-CSC medulloblastomas treated with LDE225 by RNA-seq. The gene discussed is TP53; the disease is medulloblastoma.